Quick Takeaways
- Ridgeback Capital Investments L.P. filed SCHEDULE 13G/A for Pyxis Oncology, Inc. Common Stock, par value $0.001 per share (PYXS).
- Disclosed ownership: 0.6%.
- Date of event: 31 Dec 2024.
Ridgeback Capital Investments L.P. - 31 Dec 2024 SCHEDULE 13G/A Report for Pyxis Oncology, Inc. Common Stock, par value $0.001 per share (PYXS)
- Filing Manager
- Ridgeback Capital Investments L.P.
- Reporting Manager
- Ridgeback Capital Investments L.P.
- Symbol
- PYXS
- Shares outstanding
- 59,871,833 shares
- Disclosed Ownership
- 359,231 shares
- Ownership
- 0.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 16:01:33 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Ridgeback Capital Investments L.P. disclosed 0.6% ownership in Pyxis Oncology, Inc. Common Stock, par value $0.001 per share (PYXS) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 16:01.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Ridgeback Capital Investments L.P. | 0.6% | 359,231 | 0 | 359,231 | /s/ Nicole Venezia | Nicole Venezia/General Counsel | |
| Ridgeback Capital Investments LLC | 0.6% | 359,231 | 0 | 359,231 | /s/ Nicole Venezia | Nicole Venezia/General Counsel | |
| Ridgeback Capital Management LLC | 0.6% | 359,231 | 0 | 359,231 | /s/ Nicole Venezia | Nicole Venezia/General Counsel |